XML 42 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders' Equity/(Deficit) (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Stockholders' Equity Note [Abstract] |
Estimated Fair Value of Restricted Stock Award | The estimated fair value of each RSU was calculated using the share price at the date of the grant. The following is a summary of the restricted stock awards activity during the nine months ended September 30, 2025:
| Number of Shares |  |  | Weighted-Average Grant Date Fair Value |
Unvested at December 31, 2024 |  | — |  |  | $ | — |
Granted |  | 44,879 |  |  | $ | 0.55 |
Vested |  | (44,879 | ) |  | $ | 0.55 |
Cancelled |  | — |  |  | $ | — |
Unvested at September 30, 2025 |  | — |  |  | $ | — |
Summary of Options Valued in Estimated on Date of Grant Using Black-Scholes Option-Pricing Model with Following Assumptions Used for Grants Issued | The Company used the following assumptions for the BSM to determine the fair value of the stock options granted during the nine months ended September 30, 2025.
﻿ | March 27, 2025 |
Risk free interest rate |  | 4.09 | %
Expected life (in years) | 5 |
Expected volatility |  | 119 | %
Expected dividend yield |  | 0 | %
Grant-date fair value | 0.36 |
Summary of Changes in Warrants Outstanding | The following table sets forth a summary of changes in warrants outstanding from December 31, 2024 to September 30, 2025:
| Number of |  |  | Weighted-Average |
| Warrants |  |  | Exercise Price |
Balance at December 31, 2024 |  | 10,727,387 |  |  | $ | 2.30 |
Issued |  | — |  |  | $ | — |
Exercised |  | (460,000 | ) |  | $ | 1.10 |
Cancellation/Expiration |  | — |  |  | $ | — |
Balance at September 30, 2025 |  | 10,267,387 |  |  | $ | 2.36 |

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration